WA
TTPH

WFG Advisors’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

WFG Advisors’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-230
Closed -$21K – 1735
2016
Q1 		$21K Buy
230
+70
+44% +$6.99K 0.01% 883
2015
Q4 		$32K Hold
160
– – 0.01% 781
2015
Q3 		$24K Buy
+160
New +$117K 0.01% 846

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

WFG Advisors's TTPH Position: Q2 2016 in Review

WFG Advisors sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2016, closing a stake of 230 shares — an estimated $21K sold.

WFG Advisors first reported a position in TTPH in Q3 2015 and held it in 3 quarters. The position peaked at $32K in Q4 2015. 91 funds tracked by Wall St. Rank hold TTPH as of Q2 2016.

  • WFG Advisors reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • WFG Advisors sold 230 Tetraphase Pharmaceuticals, Inc. shares in Q2 2016, an estimated $21K.
  • WFG Advisors first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2015 and held it in 3 quarters.
  • WFG Advisors's Tetraphase Pharmaceuticals, Inc. position peaked at $32K in Q4 2015.
  • 91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2016.

Based on WFG Advisors's 13F filing for Q2 2016, filed 11 Aug 2016.